文献速递神经儿科影像MR

儿童至少连续10次钆布醇给药对T1加权MRI脑信号强度比的影响:匹配病例对照研究

Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
PubMed 文献 · AJR Am J Roentgenol · 2020-10-28

该匹配病例对照研究纳入25例仅使用钆布醇且至少接受10次增强MRI的儿童及25例年龄性别匹配的未暴露对照,比较齿状核/小脑中脚与苍白球/丘脑信号强度比。两组信号强度比无显著差异,未见视觉T1高信号;作者认为选择钆布醇可能降低儿童钆沉积风险。

要点

  • 儿童至少10次连续钆布醇给药后,齿状核与小脑中脚、苍白球与丘脑信号强度比与未暴露对照无显著差异。
  • 所有患儿均未见齿状核或苍白球视觉T1高信号。
  • 作者认为选择钆布醇作为MRI对比剂可能降低儿童钆沉积风险,并可能帮助指导儿童GBCA给药实践。

核心结论

  • 儿童至少10次连续钆布醇给药与齿状核或苍白球T1高信号无关。

研究设计与样本

  • 匹配病例对照研究,病例组25例(男13例、女12例;平均年龄7±4岁,范围2-18岁)接受至少10次(平均15±6次,范围10-34次)仅使用钆布醇的增强MRI检查。
  • 对照组25例为年龄和性别匹配、从未暴露于钆的MRI患者。
  • 两名观察者采用3分法共识评估齿状核和苍白球视觉T1高信号;一名观察者放置ROI计算双侧齿状核与小脑中脚、苍白球与丘脑的平均信号强度比。
  • 采用Lin一致性相关系数(ρc)计算观察者间和观察者内一致性。

关键影像表现/征象

  • 无患者出现齿状核或苍白球视觉T1高信号。
  • 钆布醇组与对照组齿状核与小脑中脚信号强度比分别为0.95±0.05与0.95±0.03,差异无统计学意义(p=.67)。
  • 钆布醇组与对照组苍白球与丘脑信号强度比分别为1.05±0.06与1.04±0.06,差异无统计学意义(p=.65)。

诊断标准与关键数值

  • 视觉评估采用3分法评估齿状核和苍白球T1高信号,无患者出现视觉T1高信号。
  • 钆布醇组齿状核与小脑中脚信号强度比与年龄(r=0.355,p=.08)、增强MRI检查次数(r=0.247,p=.23)、检查间平均时间(r=0.193,p=.36)、累积钆布醇剂量(r=0.434,p=.07)均无显著相关性。
  • 钆布醇组苍白球与丘脑信号强度比与年龄(r=0.167,p=.42)、增强MRI检查次数(r=0.203,p=.33)、检查间平均时间(r=0.047,p=.82)、累积钆布醇剂量(r=0.270,p=.19)均无显著相关性。
  • 齿状核与小脑中脚及苍白球与丘脑信号强度比的观察者间和观察者内一致性均为充分(ρc=0.931-0.974)。

临床应用与阅片要点

  • 作者认为选择钆布醇作为MRI对比剂可能降低儿童钆沉积风险。
  • 作者认为该发现可能帮助指导儿童GBCA给药实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. An association is recognized between linear gadolinium-based contrast agents (GBCAs) and intracranial gadolinium retention in children. The relation between macrocyclic GBCAs and gadolinium retention remains incompletely understood. OBJECTIVE. The purpose of this study was to assess whether 10 or more administrations of the macrocyclic GBCA gadobutrol are associated with increased signal intensity (SI) in the dentate nucleus (DN) and globus pallidus (GP) on unenhanced T1-weighted MRI of children and to explore clinical variables potentially associated with T1 hyperintensity. METHODS. The case group consisted of 25 children (13 boys, 12 girls; mean age, 7 ± 4 years; range, 2-18 years) who underwent at least 10 (mean, 15 ± 6; range, 10-34) contrast-enhanced MRI examinations exclusively with gadobutrol. The control group consisted of 25 age- and sex-matched patients undergoing MRI who had never been exposed to gadolinium. Two observers in consensus using a 3-point scale assessed visual T1 hyperintensity in the DN and GP. One observer placed ROIs on T1-weighted images to mark the DN, GP, middle cerebellar peduncle (MCP), and pulvinar of the thalamus bilaterally to compute mean DN-to-MCP and GP-to-thalamus SI ratios. SI ratios were compared between the macrocyclic GBCA and control groups. In the macrocyclic GBCA group, Pearson correlation analysis was conducted between SI ratios and clinical variables. ROI measurements were repeated by the original reader and an independent reader, and interobserver and intraobserver agreement were computed by means of Lin concordance correlation coefficient (ρc). RESULTS. No patient had visual T1 hyperintensity in the DN or GP. No significant difference between the macrocyclic GBCA and control groups was observed for DN-to-MCP SI ratio (0.95 ± 0.05 vs 0.95 ± 0.03; p = .67) or GP-to-thalamus SI ratio (1.05 ± 0.06 vs 1.04 ± 0.06; p = .65). In the macrocyclic GBCA group, no significant correlation was observed between DN-to-MCP SI ratio or GP-to-thalamus SI ratio and age (r = 0.355, p = .08; r = 0.167, p = .42), number of contrast-enhanced MRI examinations (r = 0.247, p = .23; r = 0.203, p = .33), mean time between examinations (r = 0.193, p = .36; r = 0.047, p = .82), or cumulative macrocyclic GBCA dose (r = 0.434, p = .07; r = 0.270, p = .19). Interobserver and intraobserver agreement was substantial for DN-to-MCP SI and GP-to-TH SI ratios (ρc = 0.931-0.974). CONCLUSION. Ten or more serial gadobutrol administrations were not associated with T1 hyperintensity in the DN or GP of children. CLINICAL IMPACT. Selection of gadobutrol as an MRI contrast agent may reduce risk of gadolinium retention in children. The findings may help guide practices for GBCA administration to children.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Ozturk K, Nascene D. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study. AJR Am J Roentgenol. 2020. PMID: 33112200. doi:10.2214/AJR.20.24536

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。